戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ls and could be transferred to naive mice by immune serum.
2 resence or absence of heat-inactivated human immune serum.
3  could not be passively transferred with nsP immune serum.
4 ika virus and in the presence of heterotypic immune serum.
5 lative level of infection in the presence of immune serum.
6 rsed in either strain by passive transfer of immune serum.
7 ot significantly affected by the presence of immune serum.
8 ntially unaltered by the passive transfer of immune serum.
9  complement killing at low concentrations of immune serum.
10 ce could be prevented by passive transfer of immune serum.
11 significantly prolonged by administration of immune serum.
12 ently phagocytosed when opsonized with human immune serum.
13 bodies can block the protective potential of immune serum, a potential to which anti-GG antibodies ap
14 ividually) were completely resistant to host immune serum Abs, whereas variants expressing shorter al
15 oelectron microscopy using infection-derived immune serum against T. pallidum indicated that rTromp1
16 eviously showed that the passive transfer of immune serum alone does not confer immunity in the mouse
17                                              Immune serum also showed an enhanced bactericidal activi
18                          Polyclonal reovirus-immune serum also significantly decreased reovirus titer
19 fer studies demonstrated a dominant role for immune serum and a lesser role for immune cells in media
20 vity to cytotoxicity mediated by anti-PAcGM3 immune serum and complement.
21 A.4/5 using a range of vaccine and naturally immune serum and panels of monoclonal antibodies.
22 vector, adsorbed out antibodies to PS/A from immune serum, and elaborated a capsule visualized by imm
23      Immunity was passively transferred with immune serum, and recombinant monoclonal antibodies to t
24  that there is an apparent synergism between immune serum antibody and immune T cells in achieving pr
25   In this study, we investigated the role of immune serum antibody generated by immunization with a r
26 mmune mice treated with MAbs to PspA or PspA immune serum at 6 and 12 h after infection with 10 times
27 sive transfer of replication-defective virus-immune serum at physiologic concentrations to SCID or B-
28                         Further, transfer of immune serum before aerosol challenge had minimal effect
29 transfer varied amounts of H1N1-IAV-specific immune serum before H1N1-IAV infection to determine how
30 ese designs showed improvement in polyclonal immune serum binding to HCV pseudoparticles and neutrali
31 IgG2a/c was the major IgG subtype from early immune serum bound by FcgammaRI on the MPhi surface, and
32 be active as disease-resolving components in immune serum but antibody against other antigens may be
33                 Administration of Toxoplasma-immune serum, but not nonimmune serum, to vaccinated B-c
34                          Passive transfer of immune serum completely protected wild-type, but not Fcg
35                           Surprisingly, this immune serum conferred an elevated degree of passive pro
36                         Postinfection bovine immune serum contains antibodies that bound to each of t
37 us study showed that opsonization with human immune serum could either promote or antagonize phagocyt
38 production, and supplementation of mice with immune serum could promote basophilia independently of r
39                             Furthermore, rNP-immune serum could transfer protection to naive hosts in
40                                     Although immune serum cross-reacted with the ground cytoplasm of
41 f S. parasanguis FW213 with rabbit anti-FimA immune serum decreased the mean percent adherence (0.34%
42                          Passive transfer of immune serum demonstrates the protection is mediated by
43                                  Transfer of immune serum did not restore resistance in Igh-6(-/-) mi
44 , passive transfer studies suggest that DENV-immune serum does not protect against ZIKV infection.
45                          However, Toxoplasma-immune serum effectively inhibits the infection of host
46                                              Immune serum even mediated protective effects when admin
47 d the enhancement capabilities of Zika virus-immune serum for dengue virus in vitro.
48            Additionally, passive transfer of immune serum from aged vaccinated mice resulted in prote
49 unoblotting using antihistidine antibody and immune serum from an experimentally infected dog.
50                                  Analyses of immune serum from B10.Q and B10.QbetaBR mice revealed th
51 of either serum from wild-type recipients or immune serum from CCR5-deficient recipients diluted to t
52                                However, only immune serum from DeltagD-2-vaccinated, but not rgD-2-va
53 fect of Arp antiserum mimics the activity of immune serum from immunocompetent mice when such serum i
54 ts were recapitulated by passive transfer of immune serum from infected immunocompetent mice or T-cel
55         We have previously demonstrated that immune serum from mice infected with B. burgdorferi N40
56                                              Immune serum from nonhuman primates inhibited EBV-glycop
57                            However, although immune serum from T-cell-deficient mice induced disease
58 to neutralization by a longitudinal panel of immune serum from the source infected pony.
59                          Passive transfer of immune serum from these mice before challenge protected
60 ion was also achieved by passive transfer of immune serum from whole-parasite-immunized mice.
61 tion, and because passive transfer of IgG in immune serum from wild-type, but not SAP KO mice can pro
62 l of resistance increased with the volume of immune serum given, but the maximum survivable SCHU S4 c
63 insertion mutant library of S Typhimurium to immune serum identified a repertoire of S Typhimurium ge
64                                     Anti-P48 immune serum immuno-precipitated a mitochondrial protein
65 luated the protective efficacy of polyclonal immune serum in a mouse model of Ebola virus infection.
66                     The use of nonhomologous immune serum in animal studies and blood from survivors
67    B. bronchiseptica was, however, killed by immune serum in vitro, and adoptive transfer of anti-Bor
68 f absorbing anti-PlpE antibodies from bovine immune serum, indicating that PlpE is surface exposed in
69                             Heat-inactivated immune serum induced passive cutaneous anaphylaxis, sugg
70            IgGs purified from the anti-Ace A immune serum inhibited adherence of 46 degrees C-grown E
71 nity to naive mice, and show that Abp2D(RBD)-immune serum inhibits bacterial binding to fibrinogen-co
72             Previous studies have shown that immune serum is reactive against arthritis-related prote
73                                   Using DENV-immune serum, it has been shown in vitro that antibody-d
74      Our results suggest that treatment with immune serum limited the sequelae associated with infect
75                                              Immune serum made against a synthetic peptide with seque
76 e restored by passive transfer of Salmonella-immune serum, may be in part due to a reduced serovar Ty
77                             Using anti-MBP-1 immune serum, microaggregate binding to HEp-2 cells was
78 hed susceptibility to both nonimmune and VSV-immune serum neutralization.
79 ontrast to the marked protective efficacy of immune serum on reinfection, the course of primary infec
80 ffect on the inhibitory activity of the host immune serum on susceptible variants.
81               NK cells degranulating against immune serum-opsonized HSV-1-infected fibroblasts had he
82 is by rat AMs of IgG-opsonized erythrocytes, immune serum-opsonized Klebsiella pneumoniae, and IgG-op
83 eficient mice, and passive immunization with immune serum or Ag-specific IgG was sufficient to enable
84 with NS1, as well as passive transfer of NS1-immune serum or anti-NS1 mAb, prevent NS1-mediated letha
85                                  Transfer of immune serum or antibodies obtained from immunocompetent
86             In fact, passive transfer of MOG-immune serum or IgG into mice lacking CD40 on B cells bu
87 s of extracellular Tat can be neutralized by immune serum or monoclonal antibodies.
88           Prophylactic administration of LVS immune serum or purified immune IgG reduced the severity
89                                Functionally, immune serum or the mAb aggregated and induced a fusion-
90 transfer of lymphocytes, passive transfer of immune serum, or passive transfer of DbpA antiserum reve
91 lthough the invasive larvae can be killed by immune serum plus complement, immunity to the cyst stage
92 gle dominant neutralizing epitope, such that immune serum poorly inhibited a variant virus that encod
93    The N-terminal amino acid sequence of the immune serum-precipitable PstB protein was determined, a
94                                     T. cruzi immune serum prevented CD8(+) T cell functional exhausti
95 ice were dramatically reduced by transfer of immune serum prior to challenge.
96                Opsonization of bacteria with immune serum prior to intraperitoneal infection increase
97  mice can be minimized by treating them with immune serum prior to MHV-1 infection.
98                      Finally, GRP78-specific immune serum protected mice with DKA from mucormycosis.
99  challenge while normal serum or Ig-depleted immune serum provided no protection.
100                                       Col(V) immune serum, purified IgG or B cells from col(V) immune
101                                              Immune serum, purified IgG, and B cells all induced path
102 ibodies correlated with the avidity of donor immune serum (R, 0.7; P < 0.025), and this relationship
103  antibodies also were abundant in polyclonal immune serum raised against the functionally defective l
104                                   Polyclonal immune serum raised against the OG1RF-derived recombinan
105                                              Immune serum raised against the pSAT1-encoded protein re
106 fibronectin was inhibited in the presence of immune serum raised to one truncated fragment of the rep
107           Opsonization with heat-inactivated immune serum reduced the amount of attachment and phagoc
108 ected in infected recipients of IAV-specific immune serum regardless of the amount transferred.
109 . polygyrus challenge, and administration of immune serum restored protective immunity in B cell-defi
110                                              Immune serum samples from five of nine immunized monkeys
111                                              Immune serum samples promoted the opsonophagocytic killi
112 populations of DENV-reactive antibodies from immune serum samples to estimate the contribution of ser
113                                              Immune serum samples were collected from four population
114                                        MBP-1 immune serum significantly inhibited M. avium subsp. hom
115 was enhanced with anti-F. novicida DeltafopC immune serum, suggesting antibody-dependent cell-mediate
116 n whole fimbriae were used, the antifimbrial immune serum that contained a significant amount of anti
117 ion in killing of P. haemolytica when bovine immune serum that was depleted of anti-PlpE antibodies w
118 une complexes, we found that the transfer of immune serum to B cell-deficient mice could reconstitute
119   Passive transfer of physiologic amounts of immune serum to immunized, B-cell-deficient mice complet
120 ch was consistent with the ability of col(V) immune serum to induce complement-dependent cytotoxicity
121                          Indeed, transfer of immune serum to infected IL-27p28 transgenics resulted i
122                          Passive transfer of immune serum to naive mice prevented virus replication i
123                                  Transfer of immune serum to SCID mice resulted in 100% survival afte
124                 Administration of Toxoplasma-immune serum to ts-4-vaccinated CD4-deficient mice signi
125 te that passive immunization with Abp2D(RBD)-immune serum transfers immunity to naive mice, and show
126                            It was found that immune serum treatment provided 100% protection against
127 berculosis in the presence of autologous non-immune serum was associated with a 2.5-3-fold increase i
128  antiviral activity of passively transferred immune serum was lost against multiple SARS-CoV-2 strain
129  Neutralization of KSHV infection by the VLV immune serum was low but was markedly enhanced in the pr
130                      The passive transfer of immune serum was not protective.
131  from the lungs and prevent systemic spread, immune serum was passively administered i.p. to naive mi
132                       T-cell-deficient mouse immune serum was reactive to decorin binding protein A (
133  and that passive transfer of anti-influenza immune serum was therapeutic in B cell-deficient mice, b
134 e was immunized with these proteins, and the immune serum was used to screen a CEF cDNA expression li
135  infected (immune) mice or in mice receiving immune serum, we observed a significant role for neutrop
136 passively immunized with immune IgM and with immune serum were protected from challenge.
137             When IgGs purified from pools of immune serum were tested at 0.75 mg/ml in the SMFA, all
138 passive transfer of monoclonal Abs (MAbs) or immune serum with a luciferase-expressing Plasmodium yoe
139                                Adsorption of immune serum with FimA-positive S. parasanguis FW213 yie
140 molysis was reversed by preincubation of the immune serum with soluble, unconjugated peptide, indicat
141                            Adsorption of the immune serum with the loop 5 fusion peptide removed bact
142 eactivation was prevented by the transfer of immune serum, without a need to identify and target spec

 
Page Top